Breaking News Instant updates and real-time market news.

BAC

Bank of America

$27.92

-0.5 (-1.76%)

, SHLD

Sears

$0.31

-0.0901 (-22.52%)

16:25
10/15/18
10/15
16:25
10/15/18
16:25

Fly Intel: Wall Street's top stories for Monday

Stocks got off to a rocky start reflecting heightened tension between the U.S. and Saudi Arabia over the disappearance of journalist Jamal Khashoggi. In the second hour of trading the major averages pared their opening losses and moved into positive territory. The move across the flat line was the first of many as the market see-sawed, continuing the volatility it has experienced over the past couple of weeks. In the end, though, the market could not follow-up Friday's bounce back session with another day of gains. ECONOMIC EVENTS: In the U.S., retail sales undershot estimates, rising 0.1% in September, and falling 0.1% excluding autos. The Empire State index rebounded 2.1 ticks to 21.1 in October. Business inventories rose 0.5%, with sales up 0.5% too in August, as expected. The Treasury Department estimated that the budget deficit for fiscal year 2018 grew 17% to $779B, hitting its highest level since 2012. COMPANY NEWS: Bank of America (BAC) reported better than expected third quarter results, with CEO Brian Moynihan touting the bank having delivered "the highest quarterly pre-tax earnings" in the company's history... Sears (SHLD) and certain of its subsidiaries filed voluntary petitions for Chapter 11 bankruptcy relief and announced that Edward Lampert has stepped down from his role as CEO of the company, effective immediately... In M&A news, Harris Corporation (HRS) and L3 Technologies (LLL) announced a deal to combine in an all stock merger of equals. L3 shareholders will receive a fixed exchange ratio of 1.30 shares of Harris common stock for each share of L3 common stock and upon completion of the merger, Harris shareholders will own approximately 54% and L3 shareholders will own approximately 46% of the combined company... Top executives from BlackRock (BLK) and Blackstone (BX) will no longer attend a Saudi investor conference, joining JPMorgan's (JPM) CEO and Ford's (F) chairman in pulling out of the event following the disappearance of a Saudi journalist... Meanwhile, Bloomberg reported that Walmart (WMT) is seeking to create an online store that would sell other companies' video streaming services through Vudu. MAJOR MOVERS: Among the noteworthy gainers was Cambium Learning (ABCD), which rose 19% after it agreed to be acquired by Veritas Capital. Also higher was Canopy Growth (CGC), which gained 14% after it agreed to acquire the assets of Colorado-based hemp company Ebbu. The move higher in Canopy, and other cannabis stocks such as Tilray (TLRY) and Cronos Group (CRON), also comes ahead of Canada becoming the second country in the world to legalize cannabis on Wednesday. Among the notable losers was Nutrisystem (NTRI), which fell 11% after DA Davidson analyst Linda Bolton Weiser downgraded the stock to Underperform from Neutral. Also lower was Occidental Petroleum (OXY), which slid 6% after confirming it will no longer pursue the extension of the Idd El-Sharghi North Dome offshore field in Qatar INDEXES: The Dow fell 89.44, or 0.35%, to 25,250.55, the Nasdaq lost 66.15, or 0.88%, to 7,430.74, and the S&P 500 declined 16.34, or 0.59%, to 2,750.79.

BAC

Bank of America

$27.92

-0.5 (-1.76%)

SHLD

Sears

$0.31

-0.0901 (-22.52%)

HRS

Harris

$173.33

18.45 (11.91%)

LLL

L3 Technologies

$221.01

25.02 (12.77%)

BLK

BlackRock

$427.40

-0.18 (-0.04%)

BX

Blackstone

$35.17

0.3 (0.86%)

JPM

JPMorgan

$106.34

-0.54 (-0.51%)

F

Ford

$8.81

0.16 (1.85%)

WMT

Walmart

$93.85

-0.93 (-0.98%)

ABCD

Cambium Learning

$14.40

2.345 (19.46%)

CGC

Canopy Growth

$56.86

7.07 (14.20%)

NTRI

Nutrisystem

$33.10

-4.02 (-10.83%)

OXY

Occidental Petroleum

$72.24

-4.69 (-6.10%)

TLRY

Tilray

$165.71

17.56 (11.85%)

CRON

Cronos Group

$11.73

1.87 (18.97%)

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 19

    Oct

  • 21

    Oct

  • 24

    Oct

  • 28

    Oct

  • 06

    Nov

  • 15

    Nov

  • 13

    Dec

  • 26

    Feb

BAC Bank of America
$27.92

-0.5 (-1.76%)

09/19/18
OPCO
09/19/18
NO CHANGE
OPCO
Outperform
U.S. banks 'in very good shape,' says Oppenheimer, favorites include BofA, Citi
Oppenheimer analyst Chris Kotowski tells investors in a research note that the U.S. banking group is on solid footing with balance sheets less risky than at any time over the last 33 years the firm covered the group and says his favorite bank stocks are Outperform-rated Bank of America (BAC), Citi (C), CIT (CIT) and Goldman Sachs (GS). However, Kotowski notes that banks are trading at an average relative P/E of just ~66% relative to the S&P 500 and returning to a historical avg valuation of 73%-80% range would imply over a thousand basis points of outperformance by the group. In his view, the U.S. banks are, on the whole, in "very good" shape.
07/17/18
BARD
07/17/18
NO CHANGE
Target $30
BARD
Neutral
Baird would be buyers of Bank of America on weakness
Baird analyst David George said he would remain a buyer of Bank of America shares on any weakness, stating that its operating leverage was impressive in Q2 and should continue along with solid execution. George maintained his Neutral rating and $30 price target on Bank of America shares.
07/09/18
GSCO
07/09/18
NO CHANGE
GSCO
Bank of America, Morgan Stanley top ideas into Q2 earnings season, says Goldman Sachs
Goldman Sachs analyst Richard Ramsden expects Bank of America (BAC) and Morgan Stanley (MS) to beat consensus estimates in Q2. The analyst argues that both appear best positioned, while he sees risk for U.S. Bancorp (USB) and JPMorgan (JPM). Ramsden highlights Bank of America given the material valuation dislocation that looks to support the stock over time. Additionally, the analyst expects an expense and NII beat for Morgan Stanley.
09/25/18
WOLF
09/25/18
INITIATION
Target $40
WOLF
Outperform
Bank of America initiated with an Outperform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated Bank of America with an Outperform and $40 price target.
SHLD Sears
$0.31

-0.0901 (-22.52%)

09/24/18
WELS
09/24/18
NO CHANGE
WELS
Outperform
Newell weakness on potential Sears bankruptcy fears overdone, says Wells Fargo
Wells Fargo analyst Bonnie Herzog believes today's weakness in shares of Newell Brands (NWL) is likely due to concerns about a potential bankruptcy of Sears (SHLD) as well as ongoing China tariff negotiations. However, she views the move as a "complete overreaction," arguing that Newell's exposure to Sears is fairly limited. Herzog, who sees today's weakness as overblown and would be a buyer amid the weakness, reiterates her Outperform rating on Newell shares, which are down 7% to $20.28 in late morning trading.
10/12/18
MKMP
10/12/18
NO CHANGE
Target $31
MKMP
Neutral
L Brands visibility remains low despite better Sept comps, says MKM Partners
MKM Partners analyst Roxanne Meyer kept her Neutral rating and $31 price target on L Brands (LB), saying that while the company reported better than expected same store sales in September and its Victoria's Secret brand comps turned positive, its visibility remains low. The analyst lists potential catalysts for L Brands being a "strong performance of pajamas in Q4 and the reintroduction of swimwear" at VS, but also points to her "newest concern" being the likelihood of a Sears (SHLD) liquidation, which would then reduce traffic at malls where the company also has retail presence.
10/12/18
MSCO
10/12/18
NO CHANGE
Target $1.5
MSCO
Equal Weight
Morgan Stanley sees near-term pressure, long-term gain for Penney if Sears folds
Amid recent headlines regarding Sears (SHLD) adding a restructuring expert and reportedly pursuing a bankruptcy filing, Morgan Stanley analyst Kimberly Greenberger noted that she believes J.C. Penney (JCP) had the highest store overlap with Sears, K-Mart, and Sears Specialty Stores within both a quarter mile and half mile radius. If Sears closes additional stores or engages in liquidation sales, retailers in the close trade areas could experience some short-term pressure, said Greenberger, who added that Sears has already been closing stores for years. In the medium to long-term, she expects J.C. Penney and other retailers in the respective trade areas to potentially benefit from these closures. Greenberger, who views Penney's near-term debt maturities as "manageable," keeps an Equal Weight rating and $1.50 price target on the shares.
05/09/18
JEFF
05/09/18
NO CHANGE
Target $60
JEFF
Hold
Sears-Amazon tire partnership not a negative for Monro, says Jefferies
Jefferies analyst Bret Jordan kept his Hold rating and $60 price target on Monro (MNRO) after its stock price fell over 7.5% today to $52.70, saying Sears (SHLD) partnership with Amazon (AMZN) on tire installation and services is a not "transformational negative". Jordan notes that the greater transparency and price matching is not new, while Monro is "already an installer for other online sellers such as Tirerack and ATD's tirebuyer.com". The analyst adds that the agreement is not exclusive, leaving the "door open" for Monro to enter into a similar deal.
HRS Harris
$173.33

18.45 (11.91%)

10/15/18
COWN
10/15/18
NO CHANGE
Target $180
COWN
Outperform
L3 Technologies, Harris merger likely to be a winner, says Cowen
Cowen analysts Gautam Khanna and Cai Von Rumohr said the proposed merger between L3 Technologies (LLL) and Harris (HRS) looks like a very good fit with above average cost synergy potential. They believe the deal is likely to be a winner and although there are areas of overlap they do not believe it will be a problem. Von Rumohr reiterated his Outperform rating on L3 Technologies and Khanna reiterated his Outperform rating on Harris Corp. shares.
10/15/18
FBCO
10/15/18
NO CHANGE
Target $209
FBCO
Outperform
Harris price target raised to $209 from $190 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for Harris (HRS) to $209 from $190 after the company and L3 Technologies (LLL) announced an all-stock merger of equals. The analyst believes this could be "the most strategically significant and shareholder friendly" M&A deal announced since the start of the current A&D consolidation wave. He reiterates an Outperform rating on Harris' shares.
10/15/18
FBCO
10/15/18
NO CHANGE
Target $272
FBCO
Outperform
L3 Technologies price target raised to $272 from $238 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for L3 Technologies (LLL) to $272 from $238 after the company and Harris (HRS) announced an all-stock merger of equals. Though some may read into Harris buying L3 Technologies, the analyst sees this as a true merger of equals. He reiterates an Outperform rating on L3 Technologies' shares.
10/15/18
JEFF
10/15/18
NO CHANGE
Target $184
JEFF
Buy
Harris, L3 should trade up 5% on merger deal, says Jefferies
Jefferies analyst Sheila Kahyaoglu believes both Harris (HRS) and L3 Technologies (LLL) should trade up 5% following the announced merger of equals. The analyst bases this on the combined company's $3B of free cash flow generation in 2022and a 6.5% free cash flow yield, discounted back. She has a Buy rating on Harris and Hold rating on L3. Harris in premarket trading is up 5.4% to $163.25 while L3 is up 6.7% to $208.89.
LLL L3 Technologies
$221.01

25.02 (12.77%)

BLK BlackRock
$427.40

-0.18 (-0.04%)

07/17/18
GSCO
07/17/18
NO CHANGE
Target $570
GSCO
Buy
BlackRock price target lowered to $570 from $605 at Goldman Sachs
Goldman Sachs analyst Alexander Blostein lowered his price target on BlackRock to $570 after its Q2 results, which highlighted a "challenging market backdrop" along with a deceleration in the company's organic fee growth to 4% from 7%. The analyst keeps his Buy rating on BlackRock however, stating that the slowdown in fees was likely "market driven" and does not reflect "company specific weaknesses", adding that BlackRock still has the "operating flexibility to deliver above trend operating income growth, while accelerating technology revenue growth". Blostein lowers his FY18 EPS forecast to $27.57 from $27.96 and FY19 to $30.81 from $31.64 to reflect lowers asset under management levels and lower ETF fee rates partially offset by stronger technology revenues and more accretion from stock buybacks.
07/13/18
KBWI
07/13/18
UPGRADE
KBWI
Outperform
BlackRock upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Robert Lee upgraded BlackRock to Outperform saying shares deserve a premium valuation given its strong secular position and views the recent sell-off as a buying opportunity. The analyst believes BlackRock will be able to sustain an organic growth rate over time in the mid-single-digit range, driving a premium valuation versus peers. Lee trimmed his price target on BlackRock to $590 from $617.
07/13/18
07/13/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. VF Corp. (VFC) upgraded two notches to Buy from Underperform at BofA/Merrill with analyst Robert Ohmes saying he believes Vans momentum is sustainable and will be a "go-to-brand" for the back-to-school selling season. 2. United Rentals (URI) and Herc Holdings (HRI) were upgraded to Buy from Neutral at Buckingham. 3. Raymond James (RJF) upgraded to Buy from Neutral at Citi with analyst William Katz saying he still prefers alternative managers. 4. M.D.C. Holdings (MDC) upgraded to Neutral from Underweight at JPMorgan with analyst Michael Rehaut saying the current valuation appropriately reflects his outlook for above average order growth and margin expansion in 2018. 5. BlackRock (BLK) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Robert Lee saying shares deserve a premium valuation given its strong secular position and views the recent sell-off as a buying opportunity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/11/18
WELS
10/11/18
NO CHANGE
Target $510
WELS
Market Perform
BlackRock price target lowered to $510 from $545 at Wells Fargo
Wells Fargo analyst Christopher Harris lowered his price target for BlackRock to $510 from $545, while reiterating a Market Perform rating on the shares. Mainly because of strong U.S. equity market action, the analyst is increasing his estimate of September 30 assets under management by 1.3%. However, for the quarter, this earnings benefit is offset by lower fee-rate and performance fee assumptions, leading to a decrease in his Q3 EPS estimate.
BX Blackstone
$35.17

0.3 (0.86%)

09/24/18
JMPS
09/24/18
NO CHANGE
Target $43
JMPS
Outperform
Blackstone price target raised to $43 after investor day at JMP Securities
JMP Securities analyst Devin Ryan raised his price target on Blackstone shares to $43 from $39 following the company's investor day, from which he said the primary takeaway was the company's detailed roadmap for growth to $1T+ of AUM over the next eight years from $439B of total assets today. Ryan, who said Blackstone communicated a "clear line of sight" into $2 of fee-related earnings over the longer-term, keeps an Outperform rating on Blackstone shares.
09/25/18
ARGS
09/25/18
NO CHANGE
Target $46
ARGS
Buy
Blackstone price target raised to $46 from $39 at Argus
Argus analyst Stephen Biggar raised his price target on Blackstone to $46 and kept his Buy rating after its Investor Day presentation on Friday, citing the company's outlined plans to grow its assets under management to $1T from $439B currently. The analyst states that Blackstone is seeing "sees considerable growth in real estate, private equity, infrastructure, tactical opportunities and credit assets", adding that while the $1T target is "aggressive", it is also achievable, requiring "continuing cooperative economic environment and fundraising efforts". Biggar also anticipates Blackstone's "fee-related earnings component to grow significantly over the next two years" as its flagship funds reach key milestones, helping reduce earnings volatility and yielding "more consistent" dividend payouts.
09/24/18
MSCO
09/24/18
NO CHANGE
Target $48
MSCO
Overweight
Blackstone price target raised to $48 from $42 at Morgan Stanley
Morgan Stanley analyst Michael Cyprys said he came away from Blackstone's investor day more positive on the company's superior AUM and fee growth and ability to innovate. Blackstone also said a C-Corp conversion is under active consideration, which is a more positive stance than in it has expressed in the past, Cyprys tells investors. Based on expectations for strong growth in AUM, management fees and performance fee, along with the rising prospects for C-Corp conversion, Cyprys raised his price target on Blackstone shares to $48 from $42 and keeps an Overweight rating on the stock.
09/24/18
SBSH
09/24/18
NO CHANGE
Target $47.5
SBSH
Buy
Blackstone price target raised to $47.50 from $43 at Citi
Citi analyst William Katz raised his price target for Blackstone to $47.50 following last week's investor day. The analyst left constructive on the Alternatives sector and impressed by the "multitude of earnings drivers" at Blackstone. He's encouraged by the company's "growing competitive moat and longer-term opportunities" and keeps a Buy rating on the shares.
JPM JPMorgan
$106.34

-0.54 (-0.51%)

08/22/18
DBAB
08/22/18
NO CHANGE
DBAB
JPMorgan mobile launch a catalyst for industry consolidation, says Deutsche
Deutsche Bank analyst Brian Bedell believes JPMorgan's (JPM) reported rollout of online trading to its 47M customers next week should be a catalyst for online broker industry consolidation. The analyst believes the news supports his TD Ameritrade (AMTD), E-Trade (ETFC) merger scenario thesis. He points out that his model already includes "substantial" trade price compression.
09/25/18
WOLF
09/25/18
INITIATION
Target $140
WOLF
Outperform
JPMorgan initiated with an Outperform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated JPMorgan with an Outperform and $140 price target.
10/03/18
BERN
10/03/18
NO CHANGE
BERN
Amazon to be accelerant of disruption coming for healthcare, says Bernstein
Bernstein analyst Lance Wilkes believes disruption is coming for healthcare and that Amazon (AMZN) will be an accelerant of this disruption. Further, the analyst sees a parallel with the fast changes in health insurance which took place in the 90's, when health insurance changed from 90% indemnity to 80% managed care within ten years. Wilkes thinks Amazon is developing a series of business strategies for entering healthcare market segments, namely directly entering online pharmacy, creating a disruptor in the employer healthcare space through its venture with Berkshire (BRK.A) and JPMorgan (JPM), and entering digital consumer healthcare spaces including using Alexa for consumer engagement and behavior modification.
10/15/18
BMOC
10/15/18
NO CHANGE
Target $124
BMOC
Market Perform
JPMorgan price target raised to $124 from $118 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on JPMorgan to $124 after its Q3 earnings beat driven by lower than expected loan loss provision. The analyst notes that financials are "cheap again" in spite of the rising interest rates which are positive for net interest margins, better employment which is positive for credit, and regulatory relief which is positive for their capital position. Fotherinham also keeps his Market Perform rating on JPMorgan, saying its two-year forward earnings multiple is "only slightly" below its long-term historical average.
F Ford
$8.81

0.16 (1.85%)

08/20/18
MSCO
08/20/18
NO CHANGE
Target $15
MSCO
Overweight
Ford risks high, but so is potential reward, says Morgan Stanley
Morgan Stanley analyst Adam Jonas believes Ford announcing plans to spend $11B on restructuring and then canceling its investor day may have may have the unintended consequence of raising expectations for a "big bang" of action. While acknowledging the wide range of potential outcomes, Jonas has an estimate for how Ford could recognize its planned $11B in restructuring charges over a 3-5 year period to achieve annual cost reductions of about $4B, giving it a payback period of just under 3 years that would "usually [be] a very good use of capital" by automotive standards, he tells investors. Jonas maintains an Overweight rating on Ford with a $15 price target, contending that the "risks are high, but so is the potential reward."
09/10/18
SBSH
09/10/18
NO CHANGE
Target $9.9
SBSH
Neutral
Ford price target lowered to $9.90 from $10.50 at Citi
Citi analyst Itay Michaeli lowered his price target for Ford (F) to $9.90 to reflect restructuring-related calls on cash. The analyst keeps a Neutral rating on the shares and continues to maintain his preference for General Motors (GM). Ford faces both fundamental and perception problems, whereas GM just faces the latter, Michaeli tells investors in a research note. While the company must deal with some legitimate China and trade headwinds, the degree of erosion that's implied by the pullback in the shares is overdone, the analyst contends.
09/19/18
VERF
09/19/18
NO CHANGE
VERF
Sell
E-tron may not be 'Tesla killer,' but still a 'real risk,' says Vertical Group
After attending Audi's (AUDVF) launch event for its e-tron SUV, Vertical Group analyst Gordon Johnson said he sees Audi's foray in the EV space as "a real risk" to Tesla (TSLA) and other EV auto makers including Chevy (GM) and Ford (F). The Electrify America charging network, owned by a JV of Audi parent Volkswagen (VLKAY) and funded by "Dieselgate," positions Audi's fast-charging ambitions among the most robust, if not the most robust, in the U.S. currently, added Johnson. He does not see Audi's forthcoming e-tron as a "TSLA Killer," but does not "see it a stretch to think of it as a potential TSLA Model X killer," he concludes in his note to investors. Johnson keeps a Sell rating on Tesla shares.
09/26/18
LEHM
09/26/18
NO CHANGE
Target $11
LEHM
Equal Weight
Ford price target lowered to $11 from $12 at Barclays
In a research note titled "'Going Further' isn't further enough," Barclays analyst Brian Johnson lowered his price target for Ford Motor to $11 and $12 and keeps an Equal Weight rating on the name. Likely restructuring plans are not enough to get us interested, Johnson tells investors after Ford cancelled its investor day. Ford's plan borrows ideas from other manufacturers around shifting product toward trucks, exiting unattractive geographies and rationalizing architectures, the analyst contends. He says that even if successful, he sees little earnings upside and limited potential for multiple expansion for Ford shares.
WMT Walmart
$93.85

-0.93 (-0.98%)

10/11/18
BARD
10/11/18
NO CHANGE
Target $110
BARD
Outperform
Baird sees good prospects for sustained comp momentum for Walmart
Baird analyst Peter Benedict kept his Outperform rating and $110 price target on Walmart ahead of its annual investor meeting next week. The analyst sees "good" prospects for sustained momentum in the company's U.S. comps thanks to its in-store and online initiatives. Benedict adds that he remains positive on the fundamental setup for Walmart shares with added benefits of controlled costs and productivity improvements.
10/09/18
10/09/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. WALMART UPPED TO BUY AT DEUTSCHE: Deutsche Bank analyst Paul Trussell upgraded Walmart (WMT) to Buy from Hold and raised his price target for the shares to $113 from $89. The retailer is reaping returns on the many years of investment in e-commerce and customer service, Trussell said. The analyst believes Walmart is now in position to accelerate market share gains in grocery while also growing EBIT dollars and expanding return on investment. He believes Walmart's portfolio of assets is differentiated in the "rapidly changing" retail landscape. In late morning trading, Walmart is up just over 2%. KROGER CUT TO SELL AT DEUTSCHE: Deutsche Bank analyst Paul Trussell downgraded Kroger (KR) to Sell from Hold and lowered his price target for the shares to $24 from $30. Kroger's strategy to aggressively expand e-commerce capabilities, optimize space within current footprint, and compete on price "will likely be significantly more costly than the company and consensus are currently forecasting," Trussell said. The analyst, while believing Kroger may be one of the winners in food retail over the long term, thinks the "period of rapid change" in the grocery sector will likely make it challenging for the company to grow profits "while playing from a position of weakness." JEFFERIES UPGRADES BAKER HUGHES TO BUY: Jefferies analyst Brad Handler upgraded Baker Hughes (BHGE) to Buy from Hold and raised his price target for the shares to $38 from $34. Earnings power of $4 per share next decade "seems tangible," as is free cash flow conversion of greater than 90% of estimated earnings, Handler said. Further, he thinks General Electric (GE) "fire-sale" risk is small. MACQUARIE STARTS TESLA WITH AN OUTPERFORM: Macquarie analyst Maynard Um initiated Tesla (TSLA) with an Outperform rating and $430 price target, stating that he sees the company having unique potential among carmakers to be a leader in in-vehicle ecosystem platforms. In the near-term, Um also thinks Tesla has enough levers to get over its "debt maturity hump," including cash flow from ZEV credits and Model 3 sales, access to $1.2B unused debt commitment, and the potential for credit amendments. MOFFETTNATHANSON SAYS SNAP WILL NEED TO RAISE CAPITAL: MoffettNathanson analyst Michael Nathanson said he is skeptical, despite Snap (SNAP) CEO Evan Spiegel's internal memo, that the company can hit his stated 2019 goal of achieving full year positive free cash flow and profitability. Snap "is quickly running out of money," contends Nathanson, who thinks the company will need to raise capital by the middle to end of 2019. The analyst lowered his revenue estimates for 2019 and 2020 as he anticipates slower DAU and ARPU growth ahead and maintained his Neutral rating on Snap shares, though he cut his price target to $6.50 from $8.
10/09/18
10/09/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Walmart (WMT) upgraded to Buy from Hold at Deutsche Bank with analyst Paul Trussell saying the retailer is reaping returns on the many years of investment in e-commerce and customer service. 2. Cree (CREE) upgraded to Neutral from Underweight at JPMorgan with analyst Paul Coster saying he sees a more balanced risk/reward following the recent underperformance of the shares. 3. Amphenol (APH) upgraded to Buy from Neutral at Goldman Sachs with analyst Mark Delaney saying the company's "best in class" execution and "diverse" end markets position it well in a tougher cyclical environment. 4. Dominion (D) upgraded to Overweight from Neutral at JPMorgan with analyst Christopher Turnure saying the company is entering a period of balance sheet improvement, de-risked business mix and overall simplification, with or without the Scana (SCG) assets. 5. Baker Hughes (BHGE) upgraded to Buy from Hold at Jefferies with analyst Brad Handler saying earnings power of $4 per share next decade "seems tangible," as is free cash flow conversion of greater than 90% of estimated earnings. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/09/18
SBSH
10/09/18
NO CHANGE
SBSH
Buy
Walmart fiscal 2020 sales guidance could top expectations, says Citi
Citi analyst Kate McShane sees more upside than downside in shares of Walmart into the company's investment community meeting. Given the earnings headwind from Flipkart, the Street is already modeling fiscal 2020 earnings dropping 1%, McShane tells investors in a research note. Given the strength of Walmart's U.S. business, its sales guidance for fiscal 2020 could be higher than the Street, the analyst adds. She thinks investors will also be looking for signs that margins could stabilize beyond fiscal 2020. McShane keeps a Buy rating on Walmart shares.
ABCD Cambium Learning
$14.40

2.345 (19.46%)

04/23/18
RILY
04/23/18
NO CHANGE
Target $12.5
RILY
Buy
Cambium Learning selloff Friday brings buying opportunity, says B. Riley FBR
B. Riley FBR analyst Kevin Liu believes the selloff Friday in shares of Cambium Learning Group creates a buying opportunity. The company told Bloomberg Friday afternoon that it is not aware of the reason for the stock drop. Liu reiterates a Buy rating on Cambium with a $12.50 price target. The stock closed Friday down 24% to $10.30.
03/28/18
RILY
03/28/18
INITIATION
Target $12.5
RILY
Buy
Cambium Learning initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Kevin Li started Cambium Learning with a Buy rating and $12.50 price target. The analyst is positive on the company's transition from print to digital.
CGC Canopy Growth
$56.86

7.07 (14.20%)

10/12/18
VERI
10/12/18
INITIATION
VERI
Sell
Canopy Growth initiated with a Sell at Veritas
Veritas analyst Stuart Rolfe started coverage of the Canadian Cannabis sector with four Sell ratings, including a Sell on Canopy Growth, in a note entitled "End of the Rainbow." The analyst, who sees an intrinsic value of C$30 for Canopy Growth shares, notes that investors have already driven stock valuations for the eight largest publicly traded Canadian cannabis producers to a combined market cap of $55B on trailing twelve month sales of $250M while "oversupply risks are rampant." Even assuming 60% of the black market converts, Canada's cannabis industry "looks wildly overvalued," Rolfe concludes.
10/09/18
COWN
10/09/18
NO CHANGE
Target $172
COWN
Outperform
Tilray price target raised to $172 from $62 at Cowen
Cowen analyst Vivien Azer raised her price target for Tilray (TLRY) to $172 from $62 and keeps an Outperform rating on the shares. The analyst also raised her price target for Outperform-rated Canopy Growth (CGC) to C$82 from C$74.
10/05/18
PIVT
10/05/18
NO CHANGE
Target $300
PIVT
Buy
Constellation Brands price target raised to $300 from $265 at Pivotal Research
Pivotal Research analyst Timothy Ramsey said Constellation Brands reported a "beautiful quarter" and that its core business is "growing faster than anyone believed." In terms of its investment in Canopy Growth (CGC), Ramsey said that is "very likely a masterstroke." He raised his estimates for Constellation on the heels of the report, increased his price target to $300 and keeps a Buy rating on the shares.
10/05/18
MSCO
10/05/18
NO CHANGE
Target $255
MSCO
Overweight
Constellation Brands price target raised to $255 from $251 at Morgan Stanley
Morgan Stanley analyst Dara Mohsenian believes Constellation Brands' (STZ) strong beer fundamentals in Q2 should blunt some investor concerns and continues to think that the market is not appropriately valuing the company's strong long-term growth prospects in beer. The analyst, who also views negative sentiment around the company's investment in cannabis company Canopy Growth (CGC) as overblown, keeps an Overweight rating on Constellation and raised his price target to $255 from $251.
NTRI Nutrisystem
$33.10

-4.02 (-10.83%)

09/14/18
DADA
09/14/18
NO CHANGE
DADA
Neutral
Nutrisystem more likely than public peers to buy Jenny Craig, says DA Davidson
After The Wall Street Journal recently reported that private equity firm North Castle Partners is seeking a buyer of Jenny Craig, DA Davidson analyst Linda Bolton Weiser said she sees "zero probability" that Medifast (MED) would acquire it and "almost zero probability" that Weight Watchers (WTW) would buy the company. Nutrisystem (NTRI), however, has already shown an interest in adding non-cannibalizing brands to its portfolio, making it the most likely buyer of Jenny Craig among the publicly-traded weight loss companies Weiser covers, she stated. Nutrisystem, which seems to have hit a wall in growing its biggest brand, may need a bold strategic move to provide visibility on growth and expansion, added the analyst. She keeps Buy ratings on Medifast and Weight Watchers and a Neutral rating on Nutrisystem shares.
10/15/18
DADA
10/15/18
DOWNGRADE
DADA
Underperform
Nutrisystem downgraded to Underperform from Neutral at DA Davidson
10/15/18
10/15/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Parker-Hannifin (PH) and Rockwell Automation (ROK) were downgraded to Underperform from Market Perform at Cowen. 2. Nutrisystem (NTRI) downgraded to Underperform from Neutral at DA Davidson with analyst Linda Bolton Weiser saying she is less confident in the company being able to achieve the over 30% growth in Q4 EBITDA implied by its guidance and believes that the management could cut its outlook, citing "anecdotal evidence" that "steep" price discounting of as high as 29% may be continuing for Nutrisystem's reactivation customers. 3. KLA-Tencor (KLAC) downgraded to In Line from Outperform at Evercore ISI with analyst CJ Muse saying his recent data suggest that WFE orders are tracking to fall about 10% to $45B in FY19, but the decline could be as high as 20% if memory spending does not recover from the DRAM inventory glut-driven slump. 4. Delphi Technologies (DLPH) downgraded to Equal Weight at Morgan Stanley with analyst Armintas Sinkevicius citing the "surprise" CEO transition, stating that the reasons for the change at the top are not clear. 5. Monster Beverage (MNST) downgraded to In Line from Outperform at Evercore ISI with analyst Robert Ottenstein saying he sees fitness/sports energy drinks being poised to take share from traditional energy drinks. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/15/18
DADA
10/15/18
DOWNGRADE
Target $28
DADA
Underperform
Nutrisystem downgraded to Underperform at DA Davidson on continued discounting
As reported earlier, DA Davidson analyst Linda Bolton Weiser downgraded Nutrisystem to Underperform from Neutral and also lowered her price target to $28 from $40. The analyst says she is less confident in the company being able to achieve the over 30% growth in Q4 EBITDA implied by its guidance and believes that the management could cut its outlook, citing "anecdotal evidence" that "steep" price discounting of as high as 29% may be continuing for Nutrisystem's reactivation customers. Weiser further notes her concern over "deteriorating Google search trends for South Beach" while also lowering her FY18 EPS view to $1.99 from $2.06.
OXY Occidental Petroleum
$72.24

-4.69 (-6.10%)

09/18/18
09/18/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Cognizant (CTSH) upgraded to Buy from Hold at HSBC. 2. Casey's General Stores (CASY) upgraded to Buy from Neutral at Northcoast with analyst Chuck Cerankosky saying management's plan to enhance earnings growth and shareholder value is well underway as demonstrated by Q1 results. 3. Occidental Petroleum (OXY) upgraded to Buy from Hold at Edward Jones. 4. Vale (VALE) upgraded to Neutral from Underperform at Exane BNP Paribas. 5. Targa Resources (TRGP) upgraded to Outperform from Market Perform at Wells Fargo with analyst Michael Blum saying with the addition of the Grand Prix pipeline, Targa should have a fully integrated suite of natural gas liquids logistics assets from gathering and processing in the Permian to pipeline to fractionation to liquefied petroleum gas export. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/13/18
NASC
08/13/18
UPGRADE
NASC
Buy
Occidental Petroleum upgraded to Buy from Hold at National Alliance
09/27/18
PIPR
09/27/18
INITIATION
PIPR
Overweight
Occidental Petroleum assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Ryan Todd assumed coverage of Occidental Petroleum with an Overweight rating and a $90 price target.
09/18/18
EDJN
09/18/18
UPGRADE
EDJN
Buy
Occidental Petroleum upgraded to Buy from Hold at Edward Jones
TLRY Tilray
$165.71

17.56 (11.85%)

09/06/18
09/06/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. ANALYSTS WEIGH IN ON MICRON: Despite recent softness in DRAM spot pricing, the more appropriate metric for Micron Technology (MU) investors to focus on is gross margin, Deutsche Bank analyst Sidney Ho said. On gross margin, the analyst sees Micron benefiting from "solid cost improvement through technology transition" in fiscal 2019. Further, he believes the DRAM market has become more diverse, which should help offset temporary weakness in any given end market. As the company continues to execute on its technology roadmap and delivers solid operating results, Ho expects Micron's stock valuation to re-rate. He kept a Buy rating and $80 price target on Micron. However, Baird analyst Tristan Gerra said Micron is no longer a top large-cap idea, citing its valuation and the likelihood gross margins may be nearing their peak. He also noted DRAM pricing is likely peaking and NAND is in significant oversupply. Gerra maintained an Outperform rating but lowered his price target to $75 from $100 on Micron shares. ARGUS UPGRADES PG&E TO BUY: Argus analyst Jacob Kilstein upgraded PG&E (PCG) to Buy from Hold with a price target of $54, saying the company's recent California legislative victory will reduce its liability for last year's wildfire as its earnings outlook improves. Kilstein further anticipates PG&E to announce a timeline regarding its dividend reinstatement after being forced to suspend its quarterly payout on concerns about its potential wildfire damage responsibility estimated as high as $12B. NORTHLAND DOWNGRADES TILRAY TO MARKET PERFORM: Northland analyst Mike Grondahl downgraded Tilray (TLRY) to Market Perform from Outperform. While he continues to see the company playing a "huge role" in the recreational-use cannabis market in Canada and other countries and the medical market in Europe, he also believes the risk/reward is far more balanced following the recent "massive" move in the stock. JPMORGAN CUTS FRANKLIN RESOURCES TO UNDERWEIGHT: JPMorgan analyst Kenneth Worthington downgraded Franklin Resources (BEN) to Underweight from Neutral and lowered his price target for the shares to $29 from $32. The analyst believes the more recent weakness in emerging markets, and in particular in emerging market debt, will weigh on both Franklin's organic growth and earnings potential. He thinks challenges in emerging markets put additional pressure on "an already challenging growth story characterized by weak fund performance, significant outflows, and declining margins." Worthington continues to have a negative view on the asset management sector.
09/20/18
STFL
09/20/18
NO CHANGE
STFL
Top 22 Canadian cannabis stocks up 127% since Constellation pact, says Stifel
Yesterday's significant outperformance for Canadian cannabis stocks, led by Tilray (TLRY), at one point pushed the total market capitalization for Canadian Licensed Producers above $C80B, before they closed with a combined market cap of C$73B, calculates Stifel analyst Christopher Growe. Since August 15, when Constellation Brands (STZ) announced a pact to invest C$5B into Canopy Growth (CGC), the top 22 Canadian cannabis stocks are up 127% in stock price, noted Growe. A $C73B market cap in relation to what he estimates to be an addressable Canadian market of C$10B is "difficult to fathom," so valuations require global opportunities to be realized, added Growe, who said he questions the pace of development and degree of advantage for these companies. Companies in the cannabis space that can be traded in the U.S. include Aurora Cannabis (ACBFF), CV Sciences (CVSI), Canopy Growth, Cronos Group (CRON) and Tilray.
10/02/18
ROTH
10/02/18
NO CHANGE
ROTH
Neutral
Tilray price target removed on 'unprecedented volatility' at Roth Capital
Roth Capital analyst Scott Fortune removed Tilray's price target after assuming coverage of the stock, citing "unprecedented volatility." The analyst notes that Tilray has experienced extreme volatile trading, with the stock halted five times on September 19 and a 150-point trading swing on the same day. The stock has a small number of shares outstanding, significant short interest, and not many investors that can loan the stock to short sellers, he points out, adding that the cannabis industry continues to trade with extreme volatility due to M&A and partnership speculation. He reiterates a Neutral rating on the stock.
CRON Cronos Group
$11.73

1.87 (18.97%)

08/15/18
08/15/18
UPGRADE

Hold
Cronos Group upgraded to Hold on 'compelling' new initiatives at Canaccord
As previously reported, Canaccord analyst Matt Bottomley upgraded Cronos Group to Hold from Sell as he believe Cronos has added a number of "compelling" strategic initiatives, such as a supply agreement into Poland's recently legalized medical market; a partnership with MedMen in Canada; the creation of Cronos GrowCo; and the take-or-pay supply agreement with Cura Select of the U.S. Updating for these initiatives lead Bottomley to raise his price target on Cronos shares to C$7.50 from C$6.50.
10/12/18
VERI
10/12/18
INITIATION
VERI
Sell
Cronos Group initiated with a Sell at Veritas
Veritas analyst Stuart Rolfe started coverage of the Canadian Cannabis sector with four Sell ratings, including a Sell on Cronos Group, in a note entitled "End of the Rainbow." The analyst, who sees an intrinsic value of C$4.50 for Cronos shares, said that even assuming 60% of the black market converts, Canada's cannabis industry "looks wildly overvalued."
08/15/18
ADAM
08/15/18
UPGRADE
ADAM
Hold
Cronos Group upgraded to Hold from Sell at Canaccord

TODAY'S FREE FLY STORIES

XLI

Industrial Select Sector SPDR

$76.97

-0.62 (-0.80%)

, XLY

Consumer Discretionary Sector SPDR

$122.39

-0.03 (-0.02%)

15:07
10/18/19
10/18
15:07
10/18/19
15:07
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

The S&P 500 (SPX),…

XLI

Industrial Select Sector SPDR

$76.97

-0.62 (-0.80%)

XLY

Consumer Discretionary Sector SPDR

$122.39

-0.03 (-0.02%)

XLV

Health Care Select Sector SPDR

$91.86

-0.23 (-0.25%)

XLF

Financial Select Sector

$28.17

0.12 (0.43%)

XLK

Technology Select Sector SPDR

$81.05

-0.62 (-0.76%)

XLB

S&P Select Materials SPDR

$57.64

0.05 (0.09%)

XLU

Utilities SPDR

$63.86

0.26 (0.41%)

SPY

SPDR S&P 500 ETF Trust

$298.53

-0.71 (-0.24%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

IWM

iShares Trust Russell 2000 Index Fund

$152.79

-0.55 (-0.36%)

, RUT

Russell 2000 Index

$0.00

(0.00%)

15:06
10/18/19
10/18
15:06
10/18/19
15:06
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

For the week the Russell…

IWM

iShares Trust Russell 2000 Index Fund

$152.79

-0.55 (-0.36%)

RUT

Russell 2000 Index

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLGT

Teligent

$0.68

-0.0216 (-3.10%)

15:05
10/18/19
10/18
15:05
10/18/19
15:05
Hot Stocks
Teligent announces FDA approval of Gentamicin Sulfate Cream USP »

Teligent announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIA

Viacom

$24.95

-0.65 (-2.54%)

, VIAB

Viacom

$22.16

-0.45 (-1.99%)

15:05
10/18/19
10/18
15:05
10/18/19
15:05
Periodicals
Comcast, AT&T among bidders for 'South Park' streaming rights, Bloomberg says »

The creators of…

VIA

Viacom

$24.95

-0.65 (-2.54%)

VIAB

Viacom

$22.16

-0.45 (-1.99%)

CMCSA

Comcast

$45.65

-0.29 (-0.63%)

CMCSK

Comcast

$0.00

(0.00%)

DIS

Disney

$131.26

-1.11 (-0.84%)

T

AT&T

$38.45

0.63 (1.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 07

    Nov

  • 14

    Nov

  • 14

    Nov

  • 18

    Nov

  • 19

    Nov

AXP

American Express

$117.55

-1.62 (-1.36%)

15:00
10/18/19
10/18
15:00
10/18/19
15:00
Recommendations
American Express analyst commentary  »

William Blair reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 27

    Oct

  • 13

    Nov

  • 06

    Dec

MFGP

Micro Focus

$14.05

-0.52 (-3.57%)

15:00
10/18/19
10/18
15:00
10/18/19
15:00
Hot Stocks
Breaking Hot Stocks news story on Micro Focus »

Micro Focus International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MFGP

Micro Focus

$14.05

-0.52 (-3.57%)

, OTEX

OpenText

$40.35

-0.495 (-1.21%)

14:58
10/18/19
10/18
14:58
10/18/19
14:58
Hot Stocks
Micro Focus jumps after Bloomberg says rival OpenText considering takeover bid »

Shares of Micro Focus…

MFGP

Micro Focus

$14.05

-0.52 (-3.57%)

OTEX

OpenText

$40.35

-0.495 (-1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 06

    Nov

  • 19

    Nov

MFGP

Micro Focus

$14.06

-0.51 (-3.50%)

, OTEX

OpenText

$40.37

-0.475 (-1.16%)

14:54
10/18/19
10/18
14:54
10/18/19
14:54
Periodicals
Breaking Periodicals news story on Micro Focus, OpenText »

OpenText weighing…

MFGP

Micro Focus

$14.06

-0.51 (-3.50%)

OTEX

OpenText

$40.37

-0.475 (-1.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 06

    Nov

  • 19

    Nov

MFGP

Micro Focus

$14.06

-0.51 (-3.50%)

14:53
10/18/19
10/18
14:53
10/18/19
14:53
Hot Stocks
Breaking Hot Stocks news story on Micro Focus »

Micro Focus International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$36.89

0.19 (0.52%)

14:49
10/18/19
10/18
14:49
10/18/19
14:49
Periodicals
Harley-Davidson resumes LiveWire production, deliveries, TechCrunch says »

Harley-Davidson (HOG)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

FOMX

Foamix

$3.15

-0.09 (-2.78%)

14:46
10/18/19
10/18
14:46
10/18/19
14:46
Hot Stocks
Breaking Hot Stocks news story on Foamix »

Foamix trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 20

    Oct

CMCSA

Comcast

$45.60

-0.34 (-0.74%)

, CMCSK

Comcast

$0.00

(0.00%)

14:44
10/18/19
10/18
14:44
10/18/19
14:44
Periodicals
Comcast, AT&T among bidders for 'South Park' streaming rights, Bloomberg says »

Comcast's (CMCSA)…

CMCSA

Comcast

$45.60

-0.34 (-0.74%)

CMCSK

Comcast

$0.00

(0.00%)

T

AT&T

$38.38

0.555 (1.47%)

VIAB

Viacom

$22.13

-0.48 (-2.12%)

VIA

Viacom

$24.88

-0.72 (-2.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 14

    Nov

  • 14

    Nov

  • 18

    Nov

  • 19

    Nov

FDX

FedEx

$149.86

-0.805 (-0.53%)

14:38
10/18/19
10/18
14:38
10/18/19
14:38
Hot Stocks
FedEx announces launch of drone delivery pilot program in Virginia »

FedEx announced that,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 13

    Nov

  • 17

    Dec

PUMP

ProPetro Holding

$8.85

0.245 (2.85%)

14:35
10/18/19
10/18
14:35
10/18/19
14:35
Periodicals
ProPetro Holding under investigation by SEC, Reuters says »

The SEC is probing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLY

Annaly Capital

$8.77

0.1 (1.15%)

, IVZ

Invesco

$15.76

0.12 (0.77%)

14:26
10/18/19
10/18
14:26
10/18/19
14:26
Hot Stocks
Annaly Capital, Invesco named as stock picks by Bill Gross »

Bill Gross, during an…

NLY

Annaly Capital

$8.77

0.1 (1.15%)

IVZ

Invesco

$15.76

0.12 (0.77%)

D

Dominion

$82.18

-0.2 (-0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

  • 01

    Nov

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

BCS

Barclays

$8.49

0.12 (1.43%)

14:25
10/18/19
10/18
14:25
10/18/19
14:25
Options
Barclays call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 27

    Oct

  • 12

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
10/18/19
10/18
14:17
10/18/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
10/18/19
10/18
14:16
10/18/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$82.71

-1.42 (-1.69%)

14:15
10/18/19
10/18
14:15
10/18/19
14:15
Options
Diamondback Energy put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

QQQ

Invesco QQQ Trust

$192.00

-1.56 (-0.81%)

, SPY

SPDR S&P 500 ETF Trust

$298.50

-0.74 (-0.25%)

14:13
10/18/19
10/18
14:13
10/18/19
14:13
Technical Analysis
On The Fly: ETF fund flow highlights »

For the week creations…

QQQ

Invesco QQQ Trust

$192.00

-1.56 (-0.81%)

SPY

SPDR S&P 500 ETF Trust

$298.50

-0.74 (-0.25%)

IWM

iShares Trust Russell 2000 Index Fund

$152.78

-0.56 (-0.37%)

XLU

Utilities SPDR

$63.76

0.16 (0.25%)

IVV

iShares Core S&P 500

$300.17

-0.76 (-0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XEC

Cimarex Energy

$42.31

-0.36 (-0.84%)

14:05
10/18/19
10/18
14:05
10/18/19
14:05
Options
Cimarex Energy call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

SPXC

SPX Corporation

$40.48

0.265 (0.66%)

13:58
10/18/19
10/18
13:58
10/18/19
13:58
Initiation
SPX Corporation initiated  »

SPX Corporation initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 20

    Nov

  • 20

    Nov

  • 21

    Nov

  • 21

    Nov

WE

We Company

$0.00

(0.00%)

, JPM

JPMorgan

$120.80

0.41 (0.34%)

13:58
10/18/19
10/18
13:58
10/18/19
13:58
Periodicals
SoftBank, JPMorgan submit competing rescue packages for WeWork, FT says »

SoftBank (SFTBF) and…

WE

We Company

$0.00

(0.00%)

JPM

JPMorgan

$120.80

0.41 (0.34%)

SFTBF

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 27

    Oct

  • 04

    Nov

  • 21

    Nov

  • 14

    Jan

13:55
10/18/19
10/18
13:55
10/18/19
13:55
General news
Action Economics Survey results: »

Action Economics Survey…

JNJ

Johnson & Johnson

$129.11

-7.09 (-5.21%)

13:48
10/18/19
10/18
13:48
10/18/19
13:48
Recommendations
Johnson & Johnson analyst commentary  »

Credit Suisse says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 07

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.